MedTrace Logo

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients

NCT01544686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 630

Last updated 2015-12-09

No results posted yet for this study

Summary

In neutropenic cancer patients, catheter-related bloodstream infections may cause severe infections and even death. To assess the prophylactic effect of a chlorhexidine coated catheter securement dressing on the incidence of catheter-related bloodstream infections, this open, randomized trial is being carried out. CHG iv Tegaderm securement dressing will be randomized in a 1:1 fashion against Tegaderm Advanced iv securement dressing.

Conditions

  • Bloodstream Infection

Interventions

DEVICE

3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV

Patients receive the 3M™ Tegaderm CHG IV securement dressing or the 3M Tegaderm Advanced IV securement dressing after placement of a central venous catheter.

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • University of Cologne

    lead OTHER

Principal Investigators

  • Maria JG Vehreschild, Dr. med. · University Hospital of Cologne

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01544686 on ClinicalTrials.gov